Google
APLMW — APOLLOMICS INC. WARRANT (Healthcare >> Biotechnology)
APLMW FAQ
What is APLMW's P/E ratio?
APOLLOMICS INC. WARRANT (APLMW) currently trades at a P/E ratio of 19.03.
What is APLMW's ROE?
APOLLOMICS INC. WARRANT reports a Return on Equity (ROE) of 1,220.73%.
What is APLMW's dividend yield?
APOLLOMICS INC. WARRANT offers a dividend yield of 0.00%.
What is APLMW's Deepscope Quality Score?
Deepscope rates APLMW's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy APLMW?
Deepscope's AI Timing Score for APLMW is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does APLMW belong to?
APOLLOMICS INC. WARRANT is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.01
Price
0.00
(6.42%)
Day Change
|
|
|---|
APLMW, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.01 |
| PBV / Sector |
-9.53 / 4.79
|
| Earning Per Share | -0.01 |
| PE / Sector |
19.03 / 17.89
|
| PEG or PE/Growth / Sector |
-0.32 / 0.56
|
| Average 1M Daily Value |
657.657500000000
|
| Average 1W Daily Value |
266.986780000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-11 09:55:04 |
| Symbol | APLMW |
| Name | APOLLOMICS INC. WARRANT |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 0.00 |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 30.39 / 8,963.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Description: Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
